V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220021355 | 220006655 | 1.75 | 68.7 | Curative (C) | 2014-08-31 | 2014-09-03 | AML 18 TRIAL | 1 | null | 220025507 | AML18 TRIAL |
| 220021356 | 220013668 | 1.73 | 75 | null | 2019-07-23 | 2019-07-23 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220025668 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021357 | 220006718 | 1.5 | 54 | Curative (C) | 2017-01-21 | 2017-02-01 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220025802 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021358 | 220006728 | 0 | null | Curative (C) | 2014-12-04 | 2014-12-08 | Dasatinib | N | N | 220025841 | DASATINIB |
| 220021359 | 220022342 | 1.8 | 46.3 | Curative (C) | 2015-09-23 | 2015-11-15 | AML18 PILOT TRIAL | N | N | 220025945 | PILOT TRIAL |
| 220021360 | 220006749 | 1.68 | 84 | Disease modification (D) | 2017-01-24 | 2018-03-17 | Rituximab | N | N | 220025947 | RITUXIMAB |
| 220021361 | 220013720 | 0 | 47 | Curative (C) | 2014-10-27 | 2014-10-31 | Dasatinib | N | N | 220025965 | DASATINIB |
| 220021362 | 220006777 | 1.76 | 70 | Curative (C) | 2014-02-14 | 2014-02-16 | AML 18 Pilot Trial | null | N | 220026051 | PILOT TRIAL |
| 220021363 | 220006794 | 1.7 | 85 | Curative (C) | 2019-08-04 | 2019-08-04 | Dasatinib | 2 | N | 220026127 | DASATINIB |
| 220021364 | 220006797 | 1.72 | 69.4 | Disease modification (D) | 2017-03-21 | 2017-06-29 | AML18 PILOT TRIAL | Y | N | 220026128 | PILOT TRIAL |
| 220021365 | 220006805 | 0 | null | Disease modification (D) | 2015-06-04 | 2015-06-18 | Dasatinib | N | N | 220026157 | DASATINIB |
| 220021366 | 220006819 | 1.7 | null | Disease modification (D) | 2019-03-09 | 2019-07-20 | Dasatinib | 99 | null | 220026210 | DASATINIB |
| 220021367 | 220006846 | 1.7 | 58.9 | Curative (C) | 2017-10-13 | 2017-10-13 | AML 18 TRIAL | 1 | N | 220026282 | AML18 TRIAL |
| 220021368 | 220006868 | null | 72.9 | Curative (C) | 2017-01-16 | 2017-01-19 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220026341 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021369 | 220006879 | 1.66 | null | null | 2018-06-07 | 2018-10-24 | Dasatinib | N | null | 220026364 | DASATINIB |
| 220021370 | 220013816 | null | 71.8 | Palliative (P) | 2017-03-20 | 2017-03-20 | AML 18 TRIAL | N | N | 220026565 | AML18 TRIAL |
| 220021371 | 220006929 | 1.73 | 61.2 | Curative (C) | 2017-10-05 | 2017-11-16 | AML18 PILOT TRIAL | N | N | 220026587 | PILOT TRIAL |
| 220021372 | 220006939 | 1.71 | 75 | Curative (C) | 2018-04-24 | 2018-05-05 | Alemtuz+Fludara+Melphalan RIC MUD | 2 | N | 220026612 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021373 | 220013835 | 1.59 | 72.8 | Curative (C) | 2014-10-02 | 2014-11-18 | AML 18 Pilot Trial | 01 | N | 220026693 | PILOT TRIAL |
| 220021374 | 220007005 | 1.63 | 72.8 | Curative (C) | 2016-07-25 | 2016-09-02 | AML18 PILOT TRIAL | Y | N | 220026840 | PILOT TRIAL |
| 220021375 | 220007010 | 1.79 | null | Curative (C) | 2018-04-08 | 2018-04-08 | Dasatinib | 99 | N | 220026878 | DASATINIB |
| 220021376 | 220007036 | 1.69 | 59 | null | 2018-10-03 | 2018-10-06 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220026961 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021378 | 220007065 | 1.5 | 78.7 | null | 2018-06-11 | 2018-06-11 | Rituximab | N | N | 220027042 | RITUXIMAB |
| 220021379 | 220007090 | 1.78 | 90.4 | Curative (C) | 2016-11-18 | 2016-11-19 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220027179 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021380 | 220021869 | 1.69 | 79 | Curative (C) | 2015-06-13 | 2015-06-13 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220027327 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021381 | 220013941 | 1.8 | 98 | Disease modification (D) | 2018-12-18 | 2018-12-24 | Dasatinib | N | N | 220027456 | DASATINIB |
| 220021382 | 220017590 | 1.8 | 94 | Curative (C) | 2017-04-05 | 2017-04-05 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220027491 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021383 | 220007164 | 0 | null | Disease modification (D) | 2016-10-26 | 2016-11-06 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220027518 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021384 | 220007171 | null | 79.3 | Curative (C) | 2014-05-25 | 2014-05-29 | Alemtuz+Fludara+Melphalan RIC MUD | 2 | N | 220027551 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021385 | 220007176 | 1.73 | 91.2 | Disease modification (D) | 2016-06-26 | 2016-08-19 | AML18 PILOT TRIAL | Y | N | 220027553 | PILOT TRIAL |
| 220021386 | 220007198 | 1.7 | 74.4 | Curative (C) | 2015-07-08 | 2015-07-08 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | Y | 220027658 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021387 | 220007206 | 1.55 | 0 | Disease modification (D) | 2015-06-01 | 2016-06-02 | Dasatinib | N | N | 220027665 | DASATINIB |
| 220021388 | 220007214 | 1.57 | 60.8 | Curative (C) | 2015-02-27 | 2015-02-27 | AML18 PILOT TRIAL | null | N | 220027691 | PILOT TRIAL |
| 220021389 | 220007217 | 1.58 | 0 | Disease modification (D) | 2016-07-01 | 2016-07-01 | Rituximab (Maintenance) | N | N | 220027703 | RITUXIMAB |
| 220021390 | 220007231 | 1.67 | null | Curative (C) | 2015-12-21 | 2017-05-05 | Dasatinib | 02 | N | 220027754 | DASATINIB |
| 220021391 | 220007248 | 1.7 | null | Curative (C) | 2017-08-17 | 2017-08-19 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220027816 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021392 | 220007267 | 0 | 74.4 | Curative (C) | 2015-09-03 | 2015-09-22 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | Y | N | 220027906 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021393 | 220017625 | 1.66 | 58.5 | Palliative (P) | 2016-06-13 | 2016-06-13 | AML 18 TRIAL | 01 | N | 220027940 | AML18 TRIAL |
| 220021394 | 220007276 | 1.7 | 82.75 | Curative (C) | 2018-10-26 | 2018-10-28 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220027944 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021395 | 220007298 | 1.81 | null | Curative (C) | 2017-05-12 | 2017-08-04 | Dasatinib | 02 | N | 220028118 | DASATINIB |
| 220021396 | 220007301 | 1.75 | 61.2 | Curative (C) | 2013-08-20 | 2013-09-26 | AML18 PILOT TRIAL | Y | N | 220028136 | PILOT TRIAL |
| 220021397 | 220014025 | 1.84 | 81.2 | Curative (C) | 2013-11-15 | 2013-11-15 | AML 18 TRIAL | N | N | 220028170 | AML18 TRIAL |
| 220021398 | 220007320 | 1.78 | 83.3 | Curative (C) | 2016-01-01 | 2016-03-22 | AML 18 Pilot Trial | 01 | N | 220028203 | PILOT TRIAL |
| 220021399 | 220007322 | 1.52 | 78.6 | Curative (C) | 2017-11-08 | 2017-11-14 | Dasatinib | N | N | 220028206 | DASATINIB |
| 220021400 | 220007325 | 1.65 | 108.2 | Curative (C) | 2018-08-31 | 2018-09-11 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220028231 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021401 | 220007339 | 1.8 | null | Curative (C) | 2018-06-23 | 2018-06-23 | AML 18 TRIAL | N | N | 220028292 | AML18 TRIAL |
| 220021402 | 220014051 | 1.55 | 79 | Curative (C) | 2014-02-18 | 2014-03-01 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220028341 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021403 | 220007360 | 1.68 | 72 | Curative (C) | 2016-01-06 | 2016-04-02 | Rituximab | N | null | 220028395 | RITUXIMAB |
| 220021404 | 220014058 | 1.8 | 0 | Disease modification (D) | 2015-02-02 | 2015-02-02 | Dasatinib | N | N | 220028396 | DASATINIB |
| 220021405 | 220007364 | 1.56 | 106 | Curative (C) | null | 2017-07-16 | Dasatinib | N | N | 220028429 | DASATINIB |